Cornerstone Financial Partners’s Bristol-Myers Squibb BMY Stock Holding History

Cornerstone Financial Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$260K	Buy	+4,227	New	+$264K	0.09%	120
2017 Q1	–	Sell	-36,585	Closed	-$2.14M	–	145
2016 Q4	$2.14M	Buy	36,585 +32,081	+712%	+$1.75M	0.68%	38
2016 Q3	$244K	Buy	4,504 +1,475	+49%	+$94.7K	0.09%	133
2016 Q2	$223K	Buy	+3,029	New	+$214K	0.08%	151
2016 Q1	–	Sell	-4,769	Closed	-$330K	–	153
2015 Q4	$330K	Buy	+4,769	New	+$315K	0.12%	115

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Financial Partners's BMY Position: Q4 2017 in Review

Cornerstone Financial Partners opened a new position in Bristol-Myers Squibb (BMY) in Q4 2017: 4,227 shares worth $260K. The stake represents 0.09% of the portfolio and ranks #120 among its holdings. This is a return to the name: Cornerstone Financial Partners previously reported a position in BMY as recently as Q4 2016.

Cornerstone Financial Partners first reported a position in BMY in Q4 2015 and has held it in 5 quarters since. The position peaked at $2.14M in Q4 2016. 1,736 funds tracked by Wall St. Rank hold BMY as of Q4 2017.

Cornerstone Financial Partners held 4,227 shares of Bristol-Myers Squibb worth $260K as of Q4 2017.
Bristol-Myers Squibb was a new Cornerstone Financial Partners position in Q4 2017.
Bristol-Myers Squibb made up 0.09% of Cornerstone Financial Partners's portfolio in Q4 2017, its #120 holding.
Cornerstone Financial Partners first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 5 quarters since.
Cornerstone Financial Partners's Bristol-Myers Squibb position peaked at $2.14M in Q4 2016.
1,736 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2017.

Based on Cornerstone Financial Partners's 13F filing for Q4 2017, filed 22 Jan 2018.